Influence of the F12-4 C>T polymorphism on hemostatic tests

Blood Coagulation and Fibrinolysis

Volumn 21, Issue 7, 2010, Pages 632-639

  Corral, Javier ^a   Antón, Ana I ^a   Quiroga, Teresa ^b   González Conejero, Rocio ^a   Pereira, Jaime ^b   Roldán, Vanessa ^a   Vicente, Vicente ^a   Mezzano, Diego ^b  

^a UNIVERSITY OF MURCIA   (Spain)

^b PONTIFICIA UNIVERSIDAD CATÓLICA DE CHILE   (Chile)

Author keywords

FXII; hemostatic tests; polymorphism

Indexed keywords

BLOOD CLOTTING FACTOR 12;

ALLELE; ARTICLE; BLEEDING; CLINICAL PRACTICE; CONTROLLED STUDY; DNA POLYMORPHISM; GENE DOSAGE; GENETIC ASSOCIATION; GENOTYPE; HEMOSTASIS; HOMOZYGOTE; HUMAN; MAJOR CLINICAL STUDY; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; PROTHROMBIN TIME; THROMBIN TIME;

ALLELES; BLOOD COAGULATION FACTORS; CASE-CONTROL STUDIES; FACTOR XII; GENE DOSAGE; GENOTYPE; HEMORRHAGE; HEMOSTASIS; HUMANS; PARTIAL THROMBOPLASTIN TIME; POLYMORPHISM, SINGLE NUCLEOTIDE; THROMBIN;

EID: 77958187517     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/MBC.0b013e32833a9048     Document Type: Article

References (32)

1. Kanaji T, Okamura T, Osaki K, Kuroiwa M, Shimoda K, Hamasaki N, et al. A common genetic polymorphism (46C to T substitution) in the 50-untranslated region of the coagulation factor XII gene is associated with low translation efficiency and decrease in plasma factor XII level. Blood 1998; 91:2010-2014. (Pubitemid 28185502)
2. Blat Y, Seiffert D. A renaissance for the contact system in blood coagulation? Thromb Haemost 2008; 99:457-460. (Pubitemid 351549278)
3. Kohler HP, Futers TS, Grant PJ. FXII (46C→T) polymorphism and in vivo generation of FXII activity: gene frequencies and relationship in patients with coronary artery disease. Thromb Haemost 1999; 81:745-747.
4. Soria JM, Almasy L, Souto JC, Bacq D, Buil A, Faure A, et al. A quantitativetrait locus in the human factor XII gene influences both plasma factor XII levels and susceptibility to thrombotic disease. Am J Hum Genet 2002; 70:567-574. (Pubitemid 34177912)
5. Zito F, Lowe GD, Rumley A, McMahon AD, Humphries SE, WOSCOPS Study Group West of Scotland Coronary Prevention Study. Association of the factor XII 46C>T polymorphism with risk of coronary heart disease (CHD) in the WOSCOPS study. Atherosclerosis 2002; 165:153-158. (Pubitemid 35223177)
6. Endler G, Mannhalter C. Polymorphisms in coagulation factor genes and their impact on arterial and venous thrombosis. Clin Chim Acta 2003; 330:31-55. (Pubitemid 36287633)
7. Tirado I, Soria JM, Mateo J, Oliver A, Souto JC, Santamaria A, et al. Association after linkage analysis indicates that homozygosity for the 46C>T polymorphism in the F12 gene is a genetic risk factor for venous thrombosis. Thromb Haemost 2004; 91:899-904. (Pubitemid 38647492)
8. Grünbacher G, Marx-Neuhold E, Pilger E, Kö ppel H, Renner W. The functional -4C>T polymorphism of the coagulation factor XII gene is not associated with deep venous thrombosis. J Thromb Haemost 2005; 3:2815-2817. (Pubitemid 41819815)
9. Bach J, Endler G, Winkelmann BR, Boehm BO, Maerz W, Mannhalter C, et al. Coagulation factor XII (FXII) activity, activated FXII, distribution of FXII C46T gene polymorphism and coronary risk. J Thromb Haemost 2008; 6:291-296. (Pubitemid 351689938)
10. Reuner KH, Jenetzky E, Aleu A, Litfin F, Mellado P, Kloss M, et al. Factor XII C46T gene polymorphism and the risk of cerebral venous thrombosis. Neurology 2008; 70:129-132.
11. Renné T, Gailani D. Role of Factor XII in hemostasis and thrombosis: clinical implications. Expert Rev Cardiovasc Ther 2007; 5:733-741. (Pubitemid 47050183)
12. Davie EW, Ratnoff OD. Waterfall sequence for intrinsic blood clotting. Science 1964; 145:1310-1312.
13. Quiroga T, Goycoolea M, Panes O, Aranda E, Martínez C, Belmont S, et al. High prevalence of bleeders of unknown cause among patients with inherited mucocutaneous bleeding. A prospective study of 280 patients and 299 controls. Haematologica 2007; 92:357-365. (Pubitemid 350143545)
14. Quiroga T, Goycoolea M, Giesen PLA, Morales M, Muñoz B, Aranda E, et al. Thrombin generation in platelet-poor plasma is normal in patients with hereditary mucocutaneous haemorrhages. Pathophysiol Haemost Thromb 2003; 33:30-35. (Pubitemid 37449293)
15. Langdell RD, Wagner RH, Brinkhous KM. Effect of antihemophilic factor on one-stage clotting tests. J Lab Clin Med 1953; 41:637-647.
16. Sabater-Lleal M, Soria JM, Bertranpetit J, Almasy L, Blangero J, Fontcuberta J, et al. Human F7 sequence is split into three deep clades that are related to FVII plasma levels. Hum Genet 2006; 118:741-751. (Pubitemid 43225020)
17. Sabater-Lleal M, Chilló n M, Howard TE, Gil E, Almasy L, Blangero J, et al. Functional analysis of the genetic variability in the F7 gene promoter. Atherosclerosis 2007; 195:262-268. (Pubitemid 350087954)
18. Kishimoto TK, Viswanathan K, Ganguly T, Elankumaran S, Smith S, Pelzer K, et al. Contaminated heparin associated with adverse clinical events and activation of the contact system. N Engl J Med 2008; 358:2457-2467. (Pubitemid 351793019)
19. Maas C, Govers-Riemslag JW, Bouma B, Schiks B, Hazenberg BP, Lokhorst HM, et al. Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 2008; 118:3208-3218.
20. Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc 2007; 82:864-873. (Pubitemid 47015468)
21. Baglin T. The measurement and application of thrombin generation. Br J Haematol 2005; 130:653-661. (Pubitemid 43906639)
22. de Visser MC, van Hylckama Vlieg A, Tans G, Rosing J, Dahm AE, Sandset PM, et al. Determinants of the APTT- and ETP-based APC sensitivity tests. J Thromb Haemost 2005; 3:1488-1494. (Pubitemid 41725208)
23. Stief TW, Wieczerzak A, Renz H. Influence of coagulation factors on extrinsic thrombin generation. Blood Coagul Fibrinolysis 2007; 18:105-112. (Pubitemid 46232829)
24. Dielis AW, Castoldi E, Spronk HM, van Oerle R, Hamulyák K, Ten Cate H, et al. Coagulation factors and the protein C system as determinants of thrombin generation in a normal population. J Thromb Haemost 2008; 6:125-131.
25. Roberts HR, Hoffman M, Monroe DM. A cell-based model of thrombin generation. Semin Thromb Hemost 2006; 32 (Suppl 1): 32-38.
26. Reiner AP, Davie EW. The physiology and biochemistry of factor IX. In: Bloom AL, Thomas DP, editors. Haemostasis and thrombosis, 3rd ed. Edinburgh: Churchill Livingstone; 1994. pp. 309-324.
27. van Hylckama Vlieg A, van der Linden IK, Bertina RM, Rosendaal FR. High levels of factor IX increase the risk of venous thrombosis. Blood 2000; 95:3678-3682. (Pubitemid 30412836)
28. Souto JC, Almasy L, Borrell M, Garí M, Martínez E, Mateo J, et al. Genetic determinants of hemostasis phenotypes in Spanish families. Circulation 2000; 101:1546-1551. (Pubitemid 30180891)
29. Vossen CY, Hasstedt SJ, Rosendaal FR, Callas PW, Bauer KA, Broze GJ, et al. Heritability of plasma concentrations of clotting factors and measures of a prethrombotic state in a protein C-deficient family. J Thromb Haemost 2004; 2:242-247.
30. Khachidze M, Buil A, Viel KR, Porter S, Warren D, Machiah DK, et al. Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural gene. J Thromb Haemost 2006; 4:1537-1545. (Pubitemid 43919181)
31. Zito F, Drummond F, Bujac SR, Esnouf MP, Morrissey JH, Humphries SE, et al. Epidemiological and genetic associations of activated factor XII concentration with factor VII activity, fibrinopeptide A concentration, and risk of coronary heart disease in men. Circulation 2000; 102:2058-2062.
32. Nielsen VG, Cohen BM, Cohen E. Effects of coagulation factor deficiency on plasma coagulation kinetics determined via thrombelastography: critical roles of fibrinogen and factors II, VII, X and XII. Acta Anaesthesiol Scand 2005; 49:222-231 (Pubitemid 40313236)